In our laboratory, protein-level analysis using immunohistochemical (IHC) staining of tissues from 243 CRC patients revealed that CYP4X1 expression was consistently increased across multiple clinicopathological factors, including TNM stage, tumor differentiation, depth of invasion, and metastasis. This evidence concerns the gene CYP4X1 and colorectal carcinoma.